Search By Initial

Cas Index 1

• 1029044-16-3 | Pexidartinib (Catalog# : 52753)pexidartinib is acapsule formulation containing a small-molecule receptor tyrosine ki
• 1415562-82-1 | PF-543 (Catalog# : 52740)PF-543 is a novel cell-permeant inhibitor of SphK1 with a Ki of 3.6 nM, PF-543 is sph
• 1190307-88-0 | PSI-7977 (Catalog# : 52718)PSI-7977(sofosbuvir) is an investigational nucleotide analog for treatment of chronic
• 1092364-38-9 | Poziotinib (Catalog# : 52634)Poziotinib(NOV120101; HM781-36B) is an irreversible Pan-HER inhibitor with IC50s of 3
• 1255517-76-0 | PF-4708671 (Catalog# : 52631)PF-4708671 is a novel cell-permeable inhibitor of S6K1 (p70 ribosomal S6 kinase 1), w
• 157716-52-4 | Perifosine (Catalog# : 52613)Perifosine (KRX-0401; D-21266; NSC 639966) is a novel Akt inhibitor with IC50 of 4.7
• 1191951-57-1 | PHT-427 (Catalog# : 52583)PHT-427 is a dual Akt and PDPK1 inhibitor (high affinity binding for the PH domains o
• 1349796-36-6 | PI3K-IN-1 (Catalog# : 52560)PI3K-IN-1 is a potent inhibitor of PI3K, more information can be found in patent WO20
• 152121-53-4 | PD 169316 (Catalog# : 52513)PD 169316 is a potent, cell-permeable and selective p38 MAP kinase inhibitor (IC50 =
• 153436-54-5 | PD153035 (Catalog# : 52223)PD153035(ZM 252868; AG 1517) is a potent and specific inhibitor of EGFR with Ki and I
• 1627676-59-8 | PFI-2 (Catalog# : 52113)PFI-2 is a potent, selective, and cell-activelysine methyltransferase SETD7inhibitor
• 1454846-35-5 | PF-06463922 (Catalog# : 51701)PF-06463922 is an orally available, ATP-competitive inhibitor of the receptor tyrosin
• 1802735-28-9 | QBS10072S (Catalog# : 25190)QBS10072S isa blood-brain-barrier (BBB) penetrative agent composed of a cytotoxic che
• 150323-78-7 | Quipazine dimaleate (Catalog# : 20462)Quipazine dimaleate is a selective 5-HT3 receptor agonist that also displays antagoni
• 1893397-65-3 | QUN97653 (Catalog# : 204507)QUN97653, also known as TBK1/IKKε-IN-5, is a dual TBK1 and IKKε inhibitor, with IC5
• 1334719-95-7 | Q-203 (Catalog# : 17106003)Q-203 is a potent, selective new drug. 
• 1135695-98-5 | Q-VD-OPH (Catalog# : 16071010)Q-VD-OPH is a selective, brain and cell permeable, highly potent and irreversible inh
• 144875-48-9 | Qesiquimod (Catalog# : 120814)Qesiquimod is a potent synthetic agonist of TLR7/TLR8 that possesses antiviral and an
• 1443361-20-3 | 3-Quinolinecarboxylic acid, 1,4-dihydro-8- methoxy-1-[(4-methoxyphenyl)methyl]-4-oxo-, ethyl ester (Catalog# : 102902)Coming soon!
• 1237744-13-6 | QNZ46 (Catalog# : 91006)QNZ46 is a noncompetitive and voltage-independent antagonist selective for NR2C/D con
• 1039760-91-2 , 2074613-88-8 [ALTERNATIVE] | Rosolutamide ( AJ-201 ; ASC-JM17 ) (Catalog# : 25196)Rosolutamide (formerly known as AJ-201, ASC-JM-17 or ALZ-002) is a nuclear factor ery
• 1575596-29-0 | Rilzabrutinib (Catalog# : 25106)Rilzabrutinib, also known as PRN1008, is a reversible covalent, selective and oral ac
• 195514-63-7 | Rimiducid (Catalog# : 25100)Rimiducid, also known as AP1903, is a lipid-permeable bivalent "dimerizer"
• 1575591-66-0 | Rilzabrutinib ( PRN1008 ) (Catalog# : 25091)Rilzabrutinib ( PRN1008 ) is an oral, reversible, covalent, small-molecule inhibitor
• 1305267-37-1 | Roginolisib (Catalog# : 25068)Roginolisib, also known as MSC2360844 and IOA-244, is a potent, orally active and sel
• 1496510-51-0 | Relacorilant (Catalog# : 25035)Relacorilant is discontinued.
• 1235733-73-9 | (Rac)-AF710B (Catalog# : 24083)AF-710B is an agonist of sigma and M1 muscarinic receptors; AF710B is an enantiomer o
• 1494684-33-1 | Risovalisib mesylate (Catalog# : 24078)CYH33 (CYH-33) is a novel potent, PI3Kα-selective inhibitor with IC50 of 5.9 nM/598
• 1423719-27-0 | (R,S)-BI 1015550 (Catalog# : 230403)BI 1015550 is a novel PDE4 inhibitor showing a preferential enzymatic inhibition of P
• 139339-45-0 | Ro 24-7429 (Catalog# : 2320201)Ro24-7429 is a potent and orally activeHIV-1transactivator proteinTatantagonist. Ro24